$9.7 Billion is the total value of Bellevue Group AG's 235 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 23.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $393,471,000 | +23.1% | 1,791,761 | +1.7% | 4.06% | +25.1% |
| ARGX | Buy | ARGENX SEsponsored adr | $349,153,000 | +17.5% | 997,038 | +1.3% | 3.60% | +19.3% |
| IONS | Buy | IONIS PHARMACEUTICALS INC | $315,106,000 | +0.5% | 10,355,123 | +10.8% | 3.25% | +2.1% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $270,888,000 | -6.0% | 3,180,551 | +5.9% | 2.79% | -4.5% |
| ABT | Buy | ABBOTT LABS | $245,704,000 | +49.9% | 1,745,801 | +25.8% | 2.53% | +52.3% |
| FATE | Buy | FATE THERAPEUTICS INC | $220,918,000 | +15.1% | 3,775,736 | +16.6% | 2.28% | +16.9% |
| ISRG | Buy | INTUITIVE SURGICAL INC | $209,998,000 | +3.8% | 584,463 | +187.1% | 2.16% | +5.4% |
| DHR | Buy | DANAHER CORPORATION | $194,708,000 | +40.0% | 591,800 | +29.6% | 2.01% | +42.2% |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $142,961,000 | -28.7% | 4,349,292 | +0.2% | 1.47% | -27.5% |
| MGNX | Buy | MACROGENICS INC | $137,396,000 | -23.2% | 8,560,462 | +0.2% | 1.42% | -22.0% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $137,319,000 | -3.4% | 3,228,004 | +0.6% | 1.42% | -1.9% |
| RLAY | Buy | RELAY THERAPEUTICS INC | $126,094,000 | +6.5% | 4,105,962 | +9.3% | 1.30% | +8.2% |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $119,340,000 | +21.2% | 921,185 | +5.9% | 1.23% | +23.1% |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $112,985,000 | +12.8% | 886,854 | +15.3% | 1.16% | +14.7% |
| AXNX | Buy | AXONICS INC | $104,833,000 | +0.1% | 1,872,014 | +16.4% | 1.08% | +1.7% |
| MOH | Buy | MOLINA HEALTHCARE INC | $100,062,000 | +119.2% | 314,582 | +87.0% | 1.03% | +122.7% |
| MYOV | Buy | MYOVANT SCIENCES LTD | $96,052,000 | -25.8% | 6,169,039 | +6.9% | 0.99% | -24.7% |
| INSM | Buy | INSMED INC | $95,908,000 | +2.9% | 3,520,861 | +4.0% | 0.99% | +4.5% |
| RVMD | Buy | REVOLUTION MEDICINES INC | $87,344,000 | -8.2% | 3,470,162 | +0.3% | 0.90% | -6.8% |
| OPCH | Buy | OPTION CARE HEALTH INC | $83,160,000 | +32.1% | 2,924,043 | +12.6% | 0.86% | +34.1% |
| KZR | Buy | KEZAR LIFE SCIENCES INC | $82,231,000 | +110.0% | 4,918,148 | +8.5% | 0.85% | +113.6% |
| AMED | Buy | AMEDISYS INC | $79,323,000 | +75.7% | 490,012 | +61.8% | 0.82% | +78.6% |
| VCRA | Buy | VOCERA COMMUNICATONS INC | $75,254,000 | +42.5% | 1,160,613 | +0.6% | 0.78% | +44.8% |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $74,448,000 | +41.4% | 826,741 | +45.3% | 0.77% | +43.6% |
| ACCD | Buy | ACCOLADE INC | $71,735,000 | -8.6% | 2,721,375 | +46.3% | 0.74% | -7.2% |
| MDT | Buy | MEDTRONIC PLC | $69,043,000 | +62.4% | 667,408 | +96.8% | 0.71% | +65.2% |
| CDNA | Buy | CAREDX INC | $66,699,000 | +3301.3% | 1,466,552 | +4639.5% | 0.69% | +3340.0% |
| TMO | Buy | THERMO FISHER SCIENTIFIC INC | $65,608,000 | +32.2% | 98,328 | +13.2% | 0.68% | +34.1% |
| CI | Buy | CIGNA CORP NEW | $56,299,000 | +29.1% | 245,174 | +12.6% | 0.58% | +31.2% |
| ADPT | Buy | ADAPTIVE BIOTECHNOLOGIES COR | $55,234,000 | +21.6% | 1,968,431 | +47.3% | 0.57% | +23.4% |
| GMED | Buy | GLOBUS MED INCcl a | $54,689,000 | -2.1% | 757,464 | +3.8% | 0.56% | -0.5% |
| EXAS | Buy | EXACT SCIENCES CORP | $50,012,000 | +22.1% | 642,582 | +49.7% | 0.52% | +24.0% |
| HALO | Buy | HALOZYME THERAPEUTICS INC | $42,924,000 | +14.5% | 1,067,500 | +15.8% | 0.44% | +16.3% |
| ABBV | Buy | ABBVIE INC | $41,554,000 | +36.2% | 306,900 | +8.5% | 0.43% | +38.1% |
| SILK | Buy | SILK RD MED INC | $40,583,000 | -5.7% | 952,433 | +21.8% | 0.42% | -4.3% |
| MASI | Buy | MASIMO CORP | $38,464,000 | +11.3% | 131,376 | +2.9% | 0.40% | +12.8% |
| HCM | Buy | HUTCHMED CHINA LTDsponsored ads | $37,777,000 | +2.6% | 1,076,870 | +7.0% | 0.39% | +4.0% |
| COO | Buy | COOPER COS INC | $34,906,000 | +13.7% | 83,319 | +12.2% | 0.36% | +15.8% |
| ATRC | Buy | ATRICURE INC | $34,665,000 | +19.2% | 498,556 | +19.3% | 0.36% | +21.0% |
| TDOC | Buy | TELADOC HEALTH INC | $33,350,000 | +21.8% | 363,216 | +68.2% | 0.34% | +23.7% |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $30,760,000 | +1844.4% | 650,591 | +1255.4% | 0.32% | +1881.2% |
| LEGN | Buy | LEGEND BIOTECH CORPsponsored ads | $30,653,000 | +111.6% | 657,656 | +129.5% | 0.32% | +115.0% |
| BNTX | Buy | BIONTECH SEsponsored ads | $29,252,000 | +743.7% | 113,466 | +793.4% | 0.30% | +762.9% |
| ILMN | Buy | ILLUMINA INC | $28,582,000 | +0.5% | 75,130 | +7.1% | 0.30% | +2.1% |
| GBIO | Buy | GENERATION BIO CO | $27,416,000 | -55.8% | 3,872,180 | +56.6% | 0.28% | -55.0% |
| OM | Buy | OUTSET MED INC | $25,838,000 | +14.3% | 560,606 | +22.7% | 0.27% | +16.2% |
| CRL | Buy | CHARLES RIV LABS INTL INC | $24,834,000 | -5.0% | 65,911 | +4.1% | 0.26% | -3.4% |
| CVS | Buy | CVS HEALTH CORP | $23,603,000 | +75.4% | 228,798 | +44.3% | 0.24% | +77.4% |
| NVRO | Buy | NEVRO CORP | $19,282,000 | -22.9% | 237,841 | +10.6% | 0.20% | -21.7% |
| WVE | Buy | WAVE LIFE SCIENCES LTD | $14,453,000 | +13.3% | 4,602,858 | +76.8% | 0.15% | +15.5% |
| AMGN | Buy | AMGEN INC | $13,082,000 | +81.2% | 58,150 | +71.3% | 0.14% | +84.9% |
| ZLAB | Buy | ZAI LAB LTDadr | $7,957,000 | -39.6% | 126,600 | +1.3% | 0.08% | -38.8% |
| PFE | Buy | PFIZER INC | $6,673,000 | +55.8% | 113,000 | +13.5% | 0.07% | +60.5% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $6,308,000 | +57.9% | 71,400 | +38.1% | 0.06% | +58.5% |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $5,238,000 | +115.5% | 38,007 | +117.2% | 0.05% | +116.0% |
| Buy | PROCEPT BIOROBOTICS CORP | $4,343,000 | -24.1% | 173,649 | +15.8% | 0.04% | -22.4% | |
| OLK | Buy | OLINK HLDG ABsponsored ads | $4,282,000 | -10.6% | 235,273 | +19.1% | 0.04% | -10.2% |
| AZN | New | ASTRAZENECA PLCsponsored adr | $3,437,000 | – | 59,000 | +100.0% | 0.04% | – |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $3,169,000 | -5.2% | 21,600 | +14.3% | 0.03% | -2.9% |
| KYMR | Buy | KYMERA THERAPEUTICS INC | $3,111,000 | +49.2% | 49,000 | +38.0% | 0.03% | +52.4% |
| BPMC | New | BLUEPRINT MEDICINES CORP | $2,731,000 | – | 25,500 | +100.0% | 0.03% | – |
| DGX | Buy | QUEST DIAGNOSTICS INC | $2,638,000 | +39.7% | 15,250 | +17.3% | 0.03% | +42.1% |
| INBX | New | INHIBRX INC | $2,205,000 | – | 50,500 | +100.0% | 0.02% | – |
| LLY | New | LILLY ELI & CO | $2,086,000 | – | 7,552 | +100.0% | 0.02% | – |
| ARCT | Buy | ARCTURUS THERAPEUTICS HLDGS | $1,540,000 | -6.6% | 41,600 | +20.6% | 0.02% | -5.9% |
| IDYA | New | IDEAYA BIOSCIENCES INC | $1,111,000 | – | 47,000 | +100.0% | 0.01% | – |
| SLN | New | SILENCE THERAPEUTICS PLCads | $1,092,000 | – | 46,666 | +100.0% | 0.01% | – |
| KRYS | New | KRYSTAL BIOTECH INC | $979,000 | – | 14,000 | +100.0% | 0.01% | – |
| TSM | New | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $42,000 | – | 346 | +100.0% | 0.00% | – |
| NIO | New | NIO INCspon ads | $25,000 | – | 780 | +100.0% | 0.00% | – |
| INFY | New | INFOSYS LTDsponsored adr | $29,000 | – | 1,130 | +100.0% | 0.00% | – |
| ASR | New | GRUPO AEROPORTUARIO DEL SUREspon adr ser b | $28,000 | – | 135 | +100.0% | 0.00% | – |
| EVTC | New | EVERTEC INC | $37,000 | – | 739 | +100.0% | 0.00% | – |
| EQIX | New | EQUINIX INC | $34,000 | – | 40 | +100.0% | 0.00% | – |
| UMC | New | UNITED MICROELECTRONICS CORPspon adr new | $32,000 | – | 2,698 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- BB Biotech AG #1
- Bellevue Asset Management AG #2
- Bellevue Asset Management (UK) Ltd. #3
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-10
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IONIS PHARMACEUTICALS INC | 31 | Q3 2023 | 9.3% |
| Vertex Pharmaceuticals Incorporated | 31 | Q3 2023 | 5.9% |
| NEUROCRINE BIOSCIENCES INC | 31 | Q3 2023 | 5.7% |
| Incyte Corporation | 31 | Q3 2023 | 5.4% |
| INTUITIVE SURGICAL INC | 31 | Q3 2023 | 4.7% |
| ABBOTT LABS | 31 | Q3 2023 | 4.6% |
| ELEVANCE HEALTH INC | 31 | Q3 2023 | 4.3% |
| UnitedHealth Group Incorporated | 31 | Q3 2023 | 3.6% |
| ALNYLAM PHARMACEUTICALS INC | 31 | Q3 2023 | 3.7% |
| Boston Scientific Corporation | 31 | Q3 2023 | 2.5% |
View Bellevue Group AG's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-02-14 |
| SC 13G | 2023-02-14 |
| 13F-HR | 2022-11-14 |
View Bellevue Group AG's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.